A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
Polman CH; O'Connor PW; Havrdova E; Hutchinson M; Kappos L; Miller DH; Phillips JT; Lublin FD; Giovannoni G; Wajgt A; Toal M; Lynn F; Panzara MA; Sandrock AW; The New England Journal Of Medicine, 2006, vol. 354, issue 9, p 899, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation